Replies to post #86630 on Biotech Values

[ghmm]

MNTA:

Thanks for posting the updated analysts information.

I don't make much of day-to-day movements especially in my biotech holdings. I hope however that people selling today aren't basing it on an analyst report correcting their mistake in royalty rate!

As Dew has pointed out the royalty rate of high single to low double digits has been characterized as such by Momenta on numerous calls. The fact that an analyst would need to correct their report would lead me to put little creditability in just about everything else they had to say (favorable or not).